BackAbbott Laboratories Overview
Abbott Laboratories

Abbott Laboratories Target Price

See Abbott Laboratories's analyst price targets ($120) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$97.5

Average Target Price

$123.3826.5% upside

8 analysts in the last 4 months

High: $134 | Low: $112

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-10-02Redburn PartnersEd Ridley-Day$12730.3% upsideOpen
2026-08-13Wolfe Research$13033.3% upsideOpen
2026-07-28UBSPatrick Wood$12528.2% upsideOpen
2026-07-20Benchmark Co.$12023.1% upsideOpen
2026-07-17Piper Sandler$11821% upsideOpen
2026-07-16BTIG$13437.4% upsideOpen
2026-07-06Evercore ISIVijay Kumar$11214.9% upsideOpen
2026-06-30Robert W. BairdDavid Rescott$12124.1% upsideOpen
2026-04-22Daiwa$925.6% downsideOpen
2026-04-20BarclaysMatt Miksic$14346.7% upsideOpen
2026-04-17UBS$11517.9% upsideOpen
2026-04-17Piper Sandler$11517.9% upsideOpen
2026-04-17Stifel Nicolaus$12023.1% upsideOpen
2026-03-13UBSDanielle Antalffy$15862.1% upsideOpen
2026-03-13New Street$14548.7% upsideOpen
2026-02-02Barclays$14245.6% upsideOpen
2026-01-29Loop Capital MarketsIlya Zubkov$12023.1% upsideOpen
2026-01-23Evercore ISI$13841.5% upsideOpen
2026-01-23UBS$13235.4% upsideOpen
2026-01-23Mizuho SecuritiesAnthony Petrone$12528.2% upsideOpen
2026-01-23Piper Sandler$13538.5% upsideOpen
2026-01-23Bernstein$12528.2% upsideOpen
2026-01-23Wells FargoLarry Biegelsen$12225.1% upsideOpen
2026-01-09BernsteinLee Hambright$15457.9% upsideOpen
2026-01-09Goldman Sachs$15255.9% upsideOpen
2026-01-05Evercore ISI$14447.7% upsideOpen
2026-01-05Barclays$16973.3% upsideOpen
2025-12-22BTIGMarie Thibault$14548.7% upsideOpen
2025-11-21Tigress Financial$14548.7% upsideOpen
2025-10-17Barclays$16266.2% upsideOpen
2025-10-16Wells Fargo$14649.7% upsideOpen
2025-10-01Goldman Sachs$15761% upsideOpen
2025-07-15RBC CapitalShagun Singh$14750.8% upsideOpen
2025-04-15RBC CapitalShagun Singh$14043.6% upsideOpen
2025-01-08BernsteinLee Hambright$13538.5% upsideOpen
2024-10-17Piper SandlerAdam Maeder$13336.4% upsideOpen
2024-10-17BernsteinLee Hambright$13841.5% upsideOpen
2024-10-16JefferiesMatthew Taylor$12528.2% upsideOpen
2024-10-16Evercore ISIVijay Kumar$12831.3% upsideOpen
2024-10-16BTIGMarie Thibault$13942.6% upsideOpen
2024-10-08OppenheimerSuraj Kalia$13033.3% upsideOpen
2024-10-08SusquehannaCharles Minervino$12023.1% upsideOpen
2024-10-08RBC CapitalShagun Singh$13033.3% upsideOpen
2024-09-19RBC CapitalJonathan Atkin$165.6569.9% upsideOpen
2024-09-19Roth CapitalScott Fortune$24.0175.4% downsideOpen
2024-09-19Piper SandlerAdam Maeder$13134.4% upsideOpen
2024-08-27JefferiesMatthew Taylor$12023.1% upsideOpen
2024-08-22CitigroupJoanne Wuensch$12730.3% upsideOpen
2024-07-18CitigroupJoanna Wiensch$11922.1% upsideOpen
2024-07-18Raymond JamesJayson Bedford$12730.3% upsideOpen

Abbott Laboratories (ABT) FAQ

Abbott Laboratories posts a target price of $120. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $120 for ABT means covering analysts, on average, see the stock 26.5% upside of $97.5 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for ABT's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Abbott Laboratories's other metric pages and overview cover the third.

Judging Abbott Laboratories against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $120 here, then scan peer and history charts to see if the gap is persistent.